- Asian Cardio Diabetes Forum 2019ACDF Brief comments: The evolving role of SGLT2 inhibitors in heart failure?
- Asian Cardio Diabetes Forum 2019ACDF Brief comments: Key challenges in reinforcing CV risk management among diabetic patients
Prof John E Deanfield
- Asian Cardio Diabetes Forum 2019Lecture: SGLT2 inhibition in CVD & Diabetes: How can we explain the benefits?
Prof. Nikolaus Marx, MD
- Asian Cardio Diabetes Forum 2019Lecture: Cardiovascular outcomes that will change diabetes practice: What are the key findings from recent trials
Prof. Mark Cooper, MD